|
(3R,6S,9R,9aR)-9-Methyl-6-[3(S)-methyl-2(S)-sulfanylpentanamido]-5-oxooctahydrothiazolo[3,2-a]azepine-3-carboxylic acid |
177566-01-7; 177359-23-8 (diastereomer) |
C16H26N2O4S2 |
|
[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl]-1-[4-[2-(1-piperidinyl)ethylsulfanyl]phenyl]metanone |
|
C28H27NO3S2 |
|
2,3,4,5,-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 2,3,4,5-Tetrahydro-1-phenyl-1H-3-benzazepine-7,8-diol |
020012-10-6 (HBr); 062717-42-4 (HCl); 062751-59-1 |
C16H17NO2 |
|
3-(3,4-Difluorophenoxy)-5,5-dimethyl-4-[4-(methylsulfonyl)phenyl]furan-2(5H)-one |
|
C19H16F2O5S |
|
2-[6-(4-Amidino-2-fluorobenzamido)-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl]acetic acid trifluoroacetate |
|
C20H18FN3O4.C2HF3O2 |
|
17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium bromide; N-Methylnaltrexone bromide |
073232-52-7; 083387-25-1 (cation); 073232-53-8 (io |
C21H26NO4.Br |
|
N,N”-(2-Hydroxypropane-1,3-diyl)bis[N’-[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[2(S)-hydroxypropionamido]-2,4,6-triiodo-1,3-benzenedicarboxamide]; N,N”-(2-Hydroxytrimethylene)bis[N’-[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-5-[(S)-lactamido]isophth |
141660-63-1 |
C31H36I6N6O13 |
|
Acetyl-L-tyrosyl-L-lysyl-L-tryptophyl-L-tryptophyl-L-leucyl-L-arginyl-L-arginyl-D-alanyl-L-arginyl-L-prolyl-L-lysinamide |
|
C77H117N25O13 |
|
5-(4,5-Dihydro-2-phenyl-3H-benz[e]indol-3-yl)salicylic acid; 3-(3-Carboxy-4-hydroxy-phenyl)-2-phenyl-4,5-dihydro-3H-benz[e]indole |
053597-27-6 |
C25H19NO3 |
|
2-Hydroxy-5-[1-hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl]benzamide monohydrochloride |
032780-64-6; 036894-69-6 (free base) |
C19H24N2O3.ClH |